Commonly used gamma-emitting isotopes

Surgical experts publish updated MRONJ guidance

Retrieved on: 
Tuesday, October 18, 2022

ROSEMONT, Ill., Oct. 18, 2022 /PRNewswire/ -- The American Association of Oral and Maxillofacial Surgeons (AAOMS) has issued updated guidance for treating a rare but potentially serious jawbone condition that can impact patients taking antiresorptive medications to treat certain cancer types.

Key Points: 
  • To help patients and healthcare providers navigate this clinical concern, oral and maxillofacial surgery experts analyzed literature and revised guidance to reflect current best practices.
  • Among strategies for reducing the risk of MRONJ: maintaining good oral hygiene, performing high-risk surgical procedures prior to initiating drug therapies, quitting smoking and optimizing diabetes care.
  • Surgical management of MRONJ is increasingly considered a viable method of treatment for all stages of the disease, according to the 2022 guidance.
  • A departure from the three previous position papers, the 2022 recommendations recognize the value of surgical intervention regardless of MRONJ disease stage.

2022 Military Medical Device Technologies Report - Easy-to-Use and Quick Wound Sealing Hemostatic Solutions for Trauma Injuries Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 23, 2022

The Key Innovation Areas in Military Health Systems Include Wound Care, Health Monitoring, and Human Augmentation.

Key Points: 
  • The Key Innovation Areas in Military Health Systems Include Wound Care, Health Monitoring, and Human Augmentation.
  • US and Chinese Defense Bodies are Adopting Emerging Technologies in Military Health, Especially Digital Technologies.
  • Smart Garments and Robotic Exoskeletons are the Most Impactful Emerging Medical Technologies in Military Health Systems.
  • Hemostatic and Health Monitoring are Easy-to-Implement and Highly Impactful Solutions that Improve the Health of Military Personnel.

Azuca Introduces New SUGAR ALTERNATIVES for Fast-Acting Edibles

Retrieved on: 
Tuesday, May 17, 2022

NEW YORK, May 17, 2022 /PRNewswire/ -- Leading edibles ingredient company Azuca today announced new innovations for edibles manufacturers seeking fast-acting infusion formulas: Sugar Alternatives.

Key Points: 
  • NEW YORK, May 17, 2022 /PRNewswire/ -- Leading edibles ingredient company Azuca today announced new innovations for edibles manufacturers seeking fast-acting infusion formulas: Sugar Alternatives.
  • "As an infusion partner, AZUCA empowers manufacturers with chef-ready, infused ingredients that seamlessly integrate into production processes for fast-onset products," said Kim Sanchez Rael, President & CEO, Azuca.
  • Azuca's new sugar alternatives are manufactured and produced using our cost-effective manufacturing solution, which can reduce active ingredient waste by up to 65% compared to traditional edibles manufacturing.
  • The latest sugar alternatives compatible with AZUCA TiME INFUSION include:
    Allulose - A low-calorie sweetener that is found in products such as wheat, jackfruit, figs, and raisins.

During Breast Cancer Awareness Month, Bayer Shines a Light on the Impact of Breast Density on Breast Cancer Risk

Retrieved on: 
Monday, October 25, 2021

To learn more about breast density and its relation to breast cancer, visit Understandyourdensity.com.

Key Points: 
  • To learn more about breast density and its relation to breast cancer, visit Understandyourdensity.com.
  • Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.
  • Bayer is committed to drive sustainable development and generate a positive impact with its businesses.
  • At the same time, the Group aims to increase its earning power and create value through innovation and growth.